Welcome to our dedicated page for BlackRock Health Sciences Term Trust news (Ticker: BMEZ), a resource for investors and traders seeking the latest updates and insights on BlackRock Health Sciences Term Trust stock.
BlackRock Health Sciences Term Trust (BMEZ) announces closed-end fund developments tied to its health sciences investment mandate, common shares and net asset value mechanics. Recurring updates include managed distribution plan changes, monthly distribution rates and disclosures about return-of-capital treatment when distributions exceed income and realized gains.
The fund's news also covers Board of Trustees actions, NAV-based tender offers, final and preliminary repurchase results, shareholder agreements affecting fund governance, and related capital-structure matters for a BlackRock closed-end term trust listed under BMEZ.
BlackRock has released its first quarter commentary for the BlackRock Health Sciences Trust II (BMEZ). Since its IPO in January 2020, BMEZ has achieved a 36% market price return, outperforming the MSCI World Healthcare Index by 22%. A 45% increase in monthly distributions was announced on March 1, 2021, bringing the annualized distribution rate to 6.4%. Currently, the Trust holds 22 private investments, making up 7% of the portfolio, as it seeks to leverage illiquidity premiums.